Competition is on the horizon for costly narcolepsy treatments
pharmaphorum
DECEMBER 14, 2022
In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Furthermore, Molina stated Jazz “suppressed generic competition and raised the price of Xyrem 841% between 2007 and 2014.”
Let's personalize your content